Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Hepion Pharmaceuticals, Inc. issued 17,500,000 shares of common stock of common stock to certain accredited investors for $0.04 per share for gross proceeds of $700,000.
- Security
- common stock
- Shares
- 17,500,000 shares of common stock
- Purchaser
- certain accredited investors
- Consideration
- $0.04 per share for gross proceeds of $700,000
Exact text from the filing
On April 21, 2026, Hepion Pharmaceuticals, Inc. (the “Company”) entered into securities purchase agreements (the “Agreements”) with certain accredited investors (the “Investors”) pursuant to which the Company agreed to sell and issue to the Investors in a private placement offering (the “Offering”), an aggregate offering of 17,500,000 shares of common stock, par value $0.0001 per share (the “Common Stock”) at an offering price of $0.04 per share for gross proceeds of $700,000.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
Hepion Pharmaceuticals, Inc. entered into securities purchase agreements with certain accredited investors valued at $700,000 (effective 2026-04-21).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain accredited investors
- Value
- $700,000
- Effective
- 2026-04-21
Exact text from the filing
On April 21, 2026, Hepion Pharmaceuticals, Inc. (the “Company”) entered into securities purchase agreements (the “Agreements”) with certain accredited investors (the “Investors”) pursuant to which the Company agreed to sell and issue to the Investors in a private placement offering (the “Offering”), an aggregate offering of 17,500,000 shares of common stock, par value $0.0001 per share (the “Common Stock”) at an offering price of $0.04 per share for gross proceeds of $700,000.
View on SEC.gov